1. Home
  2. PTLE vs INM Comparison

PTLE vs INM Comparison

Compare PTLE & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • INM
  • Stock Information
  • Founded
  • PTLE 2013
  • INM 1981
  • Country
  • PTLE Singapore
  • INM Canada
  • Employees
  • PTLE N/A
  • INM N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTLE Energy
  • INM Health Care
  • Exchange
  • PTLE Nasdaq
  • INM Nasdaq
  • Market Cap
  • PTLE 6.1M
  • INM 5.0M
  • IPO Year
  • PTLE 2024
  • INM N/A
  • Fundamental
  • Price
  • PTLE $0.16
  • INM $2.04
  • Analyst Decision
  • PTLE
  • INM
  • Analyst Count
  • PTLE 0
  • INM 0
  • Target Price
  • PTLE N/A
  • INM N/A
  • AVG Volume (30 Days)
  • PTLE 3.9M
  • INM 116.2K
  • Earning Date
  • PTLE 01-01-0001
  • INM 11-13-2025
  • Dividend Yield
  • PTLE N/A
  • INM N/A
  • EPS Growth
  • PTLE N/A
  • INM N/A
  • EPS
  • PTLE N/A
  • INM N/A
  • Revenue
  • PTLE $98,133,646.00
  • INM $4,942,633.00
  • Revenue This Year
  • PTLE N/A
  • INM N/A
  • Revenue Next Year
  • PTLE N/A
  • INM N/A
  • P/E Ratio
  • PTLE N/A
  • INM N/A
  • Revenue Growth
  • PTLE N/A
  • INM 7.50
  • 52 Week Low
  • PTLE $0.14
  • INM $1.72
  • 52 Week High
  • PTLE $15.78
  • INM $8.27
  • Technical
  • Relative Strength Index (RSI)
  • PTLE 45.77
  • INM 42.37
  • Support Level
  • PTLE $0.15
  • INM $2.04
  • Resistance Level
  • PTLE $0.17
  • INM $2.26
  • Average True Range (ATR)
  • PTLE 0.01
  • INM 0.14
  • MACD
  • PTLE -0.00
  • INM -0.01
  • Stochastic Oscillator
  • PTLE 33.00
  • INM 10.44

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: